Prevention of Coronary Heart Disease in Clinical Practice. Summary of Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention

Author： WOOD DAVID   BACKER GUY DE   FAERGEMAN OLE   GRAHAM IAN   MANCIA GIUSEPPE   PYÖRÄLÄ KALEVI  

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.7, Iss.5-6, 1998-12, pp. : 262-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update of antibiotic trials for secondary prevention of coronary heart disease

By Anderson JL   Muhlestein JB  

Future Cardiology, Vol. 1, Iss. 2, 2005-03 ,pp. : 225-234

Future Medicine

Access to resources Recommend Favorite

Diet and Prevention of Coronary Heart Disease in the Arab Middle East Countries

By  

Medical Principles and Practice, Vol. 11, Iss. 2, 2002-11 ,pp. : 9-16

Karger

Access to resources Recommend Favorite

Clinical utility of β-blockers for primary and secondary prevention of coronary artery disease

By Calhoun McKenzie   Cross L Brian   Cooper-DeHoff Rhonda M  

Expert Review of Cardiovascular Therapy, Vol. 11, Iss. 3, 2013-03 ,pp. : 289-291

Informa Healthcare

Access to resources Recommend Favorite

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the west of Scotland coronary prevention study

By Satar N.   Gaw A.   Scherbakova O.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 26-26

Elsevier

Access to resources Recommend Favorite

C-reactive protein and coronary heart disease: Diagnostic and therapeutic implications for primary prevention

By Rifai Nader  

Cardiovascular Toxicology, Vol. 1, Iss. 2, 2001-06 ,pp. : 153-157

Humana Press, Inc

Access to resources Recommend Favorite